Evolus CEO sells 105K shares at $9.04 each
Evolus CEO David Moatazedi disclosed an open-market sale of 105,108 EOLS shares, leaving him with just under 500,000 shares directly held.
Rhea-AI Filing Summary
Evolus, Inc. (EOLS) reported that President and Chief Executive Officer David Moatazedi sold 105,108 shares of common stock on September 2, 2026, in an open-market transaction at a weighted average price of $9.04 per share. Following this sale, he directly holds 499,592 shares of Evolus common stock.
Positive
- None.
Negative
- None.
Insights
Analyzing...
Insider Trade Summary
Net Seller: 105,108 shares
Net Sell
1 txn
Insider
MOATAZEDI DAVID
Role
See Remarks
Sold
105,108 shs ($950K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F1 | 105,108 | $9.0385 | $950K |
Holdings After Transaction:
Common Stock — 499,592 shares (Direct)
Footnotes (1)
- F1. The shares were sold in multiple trades at prices ranging from $9.00 to $9.13. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
Key Figures
Shares sold: 105,108 shares
Weighted average sale price: $9.04 per share
Price range of individual trades: $9.00–$9.13 per share
+1 more
4 metrics
Shares sold
105,108 shares
Common stock sale by CEO on September 2, 2026
Weighted average sale price
$9.04 per share
Open-market or private sale of common stock
Price range of individual trades
$9.00–$9.13 per share
Multiple trades comprising the reported sale
Shares held after transaction
499,592 shares
CEO’s direct ownership following the sale
Key Terms
weighted average sale price, open market or private transaction, Form 4
3 terms
weighted average sale price financial
"The price reported above reflects the weighted average sale price."
open market or private transaction financial
"Sale in open market or private transaction"
Form 4 regulatory
"disclosed in a Form 4 insider transaction report"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
FAQ
What insider transaction did EOLS report for CEO David Moatazedi?
Evolus reported that CEO David Moatazedi sold 105,108 shares of common stock on September 2, 2026, in an open-market transaction at a weighted average price of $9.04 per share, leaving him with 499,592 shares directly held afterward.
Was the EOLS insider sale made under a Rule 10b5-1 trading plan?
No. The filing’s Rule 10b5-1 checkbox is not marked as being made under a trading plan, and the footnotes do not state that the sale was pursuant to a Rule 10b5-1 plan.
What does the Form 4 footnote say about the EOLS sale prices?
The footnote states the shares were sold in multiple trades at prices ranging from $9.00 to $9.13 per share, and that the reported price is the weighted average sale price. Full trade details are available upon request.
AI-generated analysis. How Rhea-AI works. Not financial advice.